WHO announces three new drugs for latest COVID-19 ‘Solidarity’ clinical trials
The therapies — artesunate, imatinib and infliximab — will be tested on hospitalized COVID-19 patients in 52 countries under the Solidarity PLUS programme. WHO’s #COVID19 Solidarity clinical trial enters a new phase – Solidarity PLUS – with three new candidate drugs:-artesunate-imatinib-infliximab 👉 https://t.co/K6tk22NnFf — World Health Organization (WHO) (@WHO) August 11, 2021 There have been more than 203 million…
Read More
